An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Voice Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users administering products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer laws, risking penalties, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the platform has removed problematic material and banned associated keywords and search suggestions. The organization stated it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.
Online Trading Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.
Within minutes of joining one community, a vendor shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts display black plastic parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service stated it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her staff has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant health risks”.
